Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Aeroflot will finalize insurance settlements with lessors by the end of the year

8/14/23 AFLT

First line of Arctic LNG 2 delivered to the installation site

8/14/23 NVTK

The 3M announced a quarterly dividend

8/11/23 MMM

Raspadskaya expects production to remain at 2022 levels

8/11/23 RASP

Rostelecom has no plans to sell its tower company

8/11/23 RTKM

Softline reported for 6 months of 2023 by IFRS

8/11/23 SOFL

Softline reported for 6 months of 2023 by IFRS

8/11/23 SFTL

PhosAgro reports for 6 months of 2023 by RAS

8/11/23 PHOR

Rostelecom is looking for a replacement for Veb Ventures in the TEA NEXT project

8/11/23 RTKM

Bank Uralsib reported for 6 months of 2023 by RAS

8/11/23 USBN